Maria E Sbrogio-Almeida
Overview
Explore the profile of Maria E Sbrogio-Almeida including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Parenteral Adjuvant Effects of an Enterotoxigenic Escherichia coli Natural Heat-Labile Toxin Variant
Braga C, Rodrigues J, Medina-Armenteros Y, Farinha-Arcieri L, Ventura A, Boscardin S, et al.
Front Immunol
. 2014 Jan;
4:487.
PMID: 24432018
Native type I heat-labile toxins (LTs) produced by enterotoxigenic Escherichia coli (ETEC) strains exert strong adjuvant effects on both antibody and T cell responses to soluble and particulate antigens following...
2.
Goncalves V, Dias W, Campos I, Liberman C, Sbrogio-Almeida M, Silva E, et al.
Vaccine
. 2013 Dec;
32(9):1113-20.
PMID: 24342254
Pneumococcal infections impose a large burden of disease on the human population, mainly in developing countries, and the current pneumococcal vaccines offer serotype-specific protection, but do not cover all pathogenic...
3.
Rojas R, Gomes P, Bentancor L, Sbrogio-Almeida M, Costa S, Massis L, et al.
Clin Vaccine Immunol
. 2010 Feb;
17(4):529-36.
PMID: 20147499
Shiga-like toxin 2 (Stx2)-producing enterohemorrhagic Escherichia coli (referred to as EHEC or STEC) strains are the primary etiologic agents of hemolytic-uremic syndrome (HUS), which leads to renal failure and high...
4.
Braga C, Massis L, Sbrogio-Almeida M, Alencar B, Bargieri D, Boscardin S, et al.
Vaccine
. 2009 Nov;
28(5):1373-82.
PMID: 19932669
Salmonella flagellin, the flagellum structural subunit, has received particular interest as a vaccine adjuvant conferring enhanced immunogenity to soluble proteins or peptides, both for activation of antibody and cellular immune...
5.
Braga C, Rittner G, Munoz Henao J, Teixeira A, Massis L, Sbrogio-Almeida M, et al.
Infect Immun
. 2009 Feb;
77(4):1700-7.
PMID: 19204092
Paracoccidioidomycosis (PCM) is a systemic granulomatous disease caused by the dimorphic fungus Paracoccidioides brasiliensis. Anti-PCM vaccine formulations based on the secreted fungal cell wall protein (gp43) or the derived P10...
6.
Luiz W, Cavalcante R, Paccez J, Souza R, Sbrogio-Almeida M, Ferreira R, et al.
Vaccine
. 2008 Jul;
26(32):3998-4005.
PMID: 18597902
Recombinant Bacillus subtilis strains, either spores or vegetative cells, may be employed as safe and low cost orally delivered live vaccine vehicles. In this study, we report the use of...
7.
Csordas F, Perciani C, Darrieux M, Goncalves V, Cabrera-Crespo J, Takagi M, et al.
Vaccine
. 2008 Apr;
26(23):2925-9.
PMID: 18440673
The currently available anti-pneumococcal vaccines are based on capsular polysaccharide (PS), plain or conjugated to a carrier protein. Conjugated vaccines are expensive products, especially in the case of pneumococcus, in...
8.
Silva M, Cabrera-Crespo J, Sbrogio-Almeida M, Miyaji E, Ho P, Leite L, et al.
Mol Biotechnol
. 2007 Oct;
37(2):146-54.
PMID: 17914175
Streptococcus pneumoniae is the agent responsible for infections such as pneumonia, otitis media, and meningitis. Among virulence factors, the Pneumococcal surface protein A (PspA) has been shown to be immunogenic...
9.
Paccez J, Nguyen H, Luiz W, Ferreira R, Sbrogio-Almeida M, Schuman W, et al.
Vaccine
. 2007 May;
25(24):4671-80.
PMID: 17498854
Recombinant Bacillus subtilis strains, either in the form of spores or vegetative cells, may be employed as safe and low-cost vaccine vehicles. In this study, we studied the role of...
10.
Paccez J, Luiz W, Sbrogio-Almeida M, Ferreira R, Schumann W, Ferreira L
Vaccine
. 2006 Mar;
24(15):2935-43.
PMID: 16503367
Bacillus subtilis has been successfully engineered to express heterologous antigens genetically fused to surface-exposed spore coat proteins as a vaccine vehicle endowed with remarkable heat resistance and probiotic effects for...